IONSIonis Pharmaceuticals, Inc.
$42.92-41% 1Y
$42.92
$42.3652 weeks$86.50
Is the price fair?
What IONS's price assumes
Ionis Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 15.0× revenue.
15.0
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 29.8
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 29.8
- EV / EBIToperating margin −68%: the multiple describes the denominator
- not meaningful
- Market capitalisation166.2 million shares, counted Jul 23, 2026
- $7.13B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks